Home|Journals|Articles by Year|Audio Abstracts

Original Article

J App Pharm Sci. 2020; 10(Volume 10, Issue 4.000): 75-99

Forced degradation study of Efonidipine HCl Ethanolate, characterization of degradation products by LC-Q-TOF-MS and NMR

Charu P. Pandya, Sadhana J. Rajput.


Efonidipine HCl Ethanolate is an antihypertensive drug with 1, 4 dihydropyridine and phosphinane derivative. Forced degradation study was performed in Efonidipine as per the guidelines by ICH Q1A (R2). Extensive degradation was observed in alkaline condition, slight degradation was observed in photolytic condition while acidic, oxidative, thermal condition didn’t show any degradation. Degradation products were separated on Thermo Hypersil BDS C18 column (250 X 4.6 mm, 5µ), mobile phase in gradient mode using ammonium acetate buffer and acetonitrile with detection at wavelength of 254 nm. Six degradation products in alkaline and four degradation products in photolytic condition were identified by HPLC and characterized by mass spectrometry using LC-Q-TOF-MS and degradation pathway was proposed. This is the typical case of degradation where co-solvent methanol reacts with Efonidipine to form pseudo degradation products - DP1, DP4, DP5 and DP6 respectively. Three degradation products DP1, DP3 and DP4 in alkaline condition were isolated by preparative HPLC and were characterized by LC-Q-TOF-MS, 1H/13C NMR and IR techniques. By characterization with these techniques, DP1 is characterized as 3-2-(N-benzylanilino)ethyl 3-oxo-2,2-dimethylpropyl hydrogen 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl) pyridin-3-yl-3-phosphonate, DP3 is characterized as 2-(N-benzyl-N-phenylamino) ethanol, DP4 is characterized as 3-methoxy-2,2-dimethylpropyl hydrogen 1,4-dihydro-2,6-dimethyl-5-methyloxycarbonyl-4-(3-nitro)phenylpyridin-3-yl-3-phosphonate.The developed method was validated as per guidelines by ICH with respect to linearity, accuracy, precision, limit of detection and robustness.

Key words: Forced degradation, Efonidipine, Preparative HPLC, LC-Q-TOF-MS, NMR and IR

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.